1260155381067714562

Today we announced that the global, randomized Phase 3 study of our investigational advanced cell therapy, omidubicel, met its primary endpoint. We are extremely grateful to all the patients, investigators and study teams who participated in the study. https://t.co/TljfowjTOD

Send us a message